Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-09

FDA Approved: SAPROPTERIN DIHYDROCHLORIDE — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for sapropterin dihydrochloride by ENDO USA, Inc., updating regulatory authorization for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

SUPPL AP for SAPROPTERIN DIHYDROCHLORIDE (SAPROPTERIN DIHYDROCHLORIDE)